Search clinical trials for: Gusperimus

Total 5 results

Nippon Kayaku Co., Ltd.

Completed

Safety and Efficacy on Deoxyspergualin (NKT-01) in Patients With Lupus Nephritis

Lupus Nephritis

Germany, Czech Republic
Nippon Kayaku Co., Ltd.

Terminated

Efficacy and Safety of Deoxyspergualin in Renal Transplant Patient With Chronic Rejection

Chronic Rejection

Japan
Nippon Kayaku Co., Ltd.

Completed

Phase II Study on Gusperimus in Patients With Refractory Wegener's Granulomatosis

Wegener's Granulomatosis

United Kingdom, Germany, Sweden, Czech Republic, Denmark, Netherlands
Nordic Pharma SAS

Terminated

Clinical Study Comparing the New Immunosuppressive Drug Gusperimus With the Conventional Treatment in Wegener's Granulomatosis (SPARROW)

Wegeners Granulomatosis

Czech Republic
National Institute of Allergy and Infectious Diseases...
National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK)

Completed

Peritransplant Deoxyspergualin in Islet Transplantation in Type 1 Diabetes

Diabetes Mellitus, Type 1

United States

3

Subscribe